Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsHepatitis C patients in Indonesia have found it is still quite difficult for them to get effective but affordable medicines, although the government has issued a permit for the distribution of Hep C drug Sofosbuvir’s generic versions produced in India since July 2016.
Koalisi Obat Murah (KOM), a non-government group concerned with people’s right to access quality and affordable medicines, has welcomed the Health Ministry’s plan to offer a tender for the procurement of Sofosbuvir, a combined medication used to treat Hepatitis C, for 6,000 patients with the virus.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.